Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Journal of Hypertension|August 19, 2022
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of HypertensionGeorge Stergiou, Mattias Brunström, Thomas MacDonald, et al.
The Oncologist|December 21, 2018
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective AnalysisSteven M Bair, Lauren E Strelec, Tatyana A Feldman, et al.
Cell Cycle (Georgetown, Tex.)|November 22, 2017
Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignanciesVarun V Prabhu, Mala K Talekar, Amriti R Lulla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2021
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412Grzegorz S Nowakowski, Fangxin Hong, David W Scott, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 13, 2016
Research Progresses in Understanding the Pathophysiology of Moyamoya DiseaseAnna Bersano, Stephanie Guey, Gloria Bedini, et al.
Transplantation and Cellular Therapy|June 13, 2025
Clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy in patients with chronic lymphocytic leukemia on behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Javier Pinilla-Ibarz, et al.
European Journal of Medicinal Chemistry|August 11, 2023
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT<sub>6</sub>R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's diseaseKinga Czarnota-Łydka, Sylwia Sudoł-Tałaj, Katarzyna Kucwaj-Brysz, et al.
Haematologica|May 17, 2020
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomasJakub Svoboda, Steven M Bair, Daniel J Landsburg, et al.
Hypertension (Dallas, Tex. : 1979)|May 19, 2020
May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of HypertensionThomas Beaney, Aletta E Schutte, George S Stergiou, et al.
JAMA Internal Medicine|January 18, 2022
The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical TrialEmily G McDonald, Peter E Wu, Babak Rashidi, et al.
Pageof 23